App boosts PrEP use in transgender women and gay men
NCT ID NCT06159582
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study tested a mobile app called eSTEP designed to help transgender women and gay/bisexual men at high risk for HIV start and continue taking PrEP, a daily or injectable medication that prevents HIV. 116 participants used the app alongside their regular clinic visits, and researchers measured how many started PrEP and maintained protective drug levels. The goal was to see if the app improves adherence compared to standard care alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-EXPOSURE PROPHYLAXIS (PREP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
San Diego State University - Department of Psychology
San Diego, California, 92120, United States
Conditions
Explore the condition pages connected to this study.